PL1893237T3 - Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywny - Google Patents
Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywnyInfo
- Publication number
- PL1893237T3 PL1893237T3 PL06778599T PL06778599T PL1893237T3 PL 1893237 T3 PL1893237 T3 PL 1893237T3 PL 06778599 T PL06778599 T PL 06778599T PL 06778599 T PL06778599 T PL 06778599T PL 1893237 T3 PL1893237 T3 PL 1893237T3
- Authority
- PL
- Poland
- Prior art keywords
- organopolysiloxane elastomer
- pharmaceutical composition
- active principle
- solubilized active
- solubilized
- Prior art date
Links
- 229920001971 elastomer Polymers 0.000 title abstract 2
- 239000000806 elastomer Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920001296 polysiloxane Polymers 0.000 title abstract 2
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- -1 vitamin D compound Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0506183A FR2887150B1 (fr) | 2005-06-17 | 2005-06-17 | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise |
| PCT/FR2006/001357 WO2006134272A1 (fr) | 2005-06-17 | 2006-06-15 | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise |
| EP06778599A EP1893237B1 (fr) | 2005-06-17 | 2006-06-15 | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1893237T3 true PL1893237T3 (pl) | 2010-02-26 |
Family
ID=35559477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06778599T PL1893237T3 (pl) | 2005-06-17 | 2006-06-15 | Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywny |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080194528A1 (pl) |
| EP (1) | EP1893237B1 (pl) |
| JP (1) | JP2008543815A (pl) |
| AT (1) | ATE442864T1 (pl) |
| BR (1) | BRPI0613276A2 (pl) |
| CA (1) | CA2611869A1 (pl) |
| CY (1) | CY1109507T1 (pl) |
| DE (1) | DE602006009259D1 (pl) |
| DK (1) | DK1893237T3 (pl) |
| ES (1) | ES2331811T3 (pl) |
| FR (1) | FR2887150B1 (pl) |
| PL (1) | PL1893237T3 (pl) |
| PT (1) | PT1893237E (pl) |
| SI (1) | SI1893237T1 (pl) |
| WO (1) | WO2006134272A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263580B2 (en) | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| NZ563560A (en) | 2005-06-01 | 2009-11-27 | Stiefel Res Australia Pty Ltd | Vitamin formulation for treating a dermatological skin disorder |
| US20100202986A1 (en) * | 2007-07-11 | 2010-08-12 | Victor Albert Raul | Compositions For Delivering A Drug |
| EP2334285A1 (en) * | 2008-09-12 | 2011-06-22 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| WO2010072958A2 (fr) * | 2008-12-23 | 2010-07-01 | Galderma S.A. | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau |
| US20100322875A1 (en) * | 2009-06-18 | 2010-12-23 | Advanced Bio-Technologies, Inc. | Silicone scar treatment preparation |
| GB0919650D0 (en) | 2009-11-10 | 2009-12-23 | Futura Medical Developments Ltd | Pharmaceutical composition |
| MX2012007225A (es) * | 2009-12-22 | 2012-07-30 | Leo Pharma As | Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d. |
| WO2011076207A2 (en) * | 2009-12-22 | 2011-06-30 | Leo Pharma A/S | Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3943248A (en) * | 1974-11-04 | 1976-03-09 | Shulman Max J | Methods of treating burns using colophony containing preparations |
| FR2719220A1 (fr) * | 1994-04-29 | 1995-11-03 | Lafon Labor | Nouvelle forme galénique pour l'administration transdermique. |
| US6538039B2 (en) * | 1994-04-29 | 2003-03-25 | Laboratoire L. Lafon | Pharmaceutical dosage form for transdermal administration |
| FR2740038B1 (fr) * | 1995-10-20 | 1998-01-02 | Lafon Labor | Composition pour l'administration transdermique |
| US6103250A (en) * | 1999-07-06 | 2000-08-15 | Revlon Consumer Products Corporation | Anhydrous cosmetic compositions containing emulsifying siloxane elastomer |
| US6924400B2 (en) * | 2001-12-10 | 2005-08-02 | Galderma Research & Development, Snc | Triaromatic vitamin D analogues |
| FR2843962B1 (fr) * | 2002-08-27 | 2005-12-02 | Galderma Res & Dev | Analogues de la vitamine d |
| CA2496362C (en) * | 2002-08-27 | 2012-03-06 | Galderma Research & Development, S.N.C. | Analogues of vitamin d |
| AU2002368245A1 (en) * | 2002-09-26 | 2004-04-19 | Young-Kweon Choi | Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
| ATE410184T1 (de) * | 2003-02-05 | 2008-10-15 | Galderma Res & Dev | Umkehremulsion mit mindestens einem gegenüber wasser empfindlichen wirkstoff und ihre anwendungen in kosmetik und dermatologie |
| PT1686972E (pt) * | 2003-11-21 | 2008-04-23 | Galderma Res & Dev | Composição pulverizável para a administração de derivados da itamina d |
| FR2871695B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises |
-
2005
- 2005-06-17 FR FR0506183A patent/FR2887150B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-15 SI SI200630410T patent/SI1893237T1/sl unknown
- 2006-06-15 AT AT06778599T patent/ATE442864T1/de active
- 2006-06-15 DK DK06778599T patent/DK1893237T3/da active
- 2006-06-15 BR BRPI0613276-6A patent/BRPI0613276A2/pt not_active IP Right Cessation
- 2006-06-15 DE DE602006009259T patent/DE602006009259D1/de active Active
- 2006-06-15 ES ES06778599T patent/ES2331811T3/es active Active
- 2006-06-15 EP EP06778599A patent/EP1893237B1/fr not_active Not-in-force
- 2006-06-15 WO PCT/FR2006/001357 patent/WO2006134272A1/fr not_active Ceased
- 2006-06-15 CA CA002611869A patent/CA2611869A1/fr not_active Abandoned
- 2006-06-15 PL PL06778599T patent/PL1893237T3/pl unknown
- 2006-06-15 JP JP2008516377A patent/JP2008543815A/ja active Pending
- 2006-06-15 PT PT06778599T patent/PT1893237E/pt unknown
-
2007
- 2007-12-17 US US12/000,773 patent/US20080194528A1/en not_active Abandoned
-
2009
- 2009-10-22 CY CY20091101102T patent/CY1109507T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2887150A1 (fr) | 2006-12-22 |
| DE602006009259D1 (de) | 2009-10-29 |
| ATE442864T1 (de) | 2009-10-15 |
| BRPI0613276A2 (pt) | 2010-12-28 |
| EP1893237B1 (fr) | 2009-09-16 |
| JP2008543815A (ja) | 2008-12-04 |
| SI1893237T1 (sl) | 2010-03-31 |
| PT1893237E (pt) | 2009-11-03 |
| ES2331811T3 (es) | 2010-01-15 |
| CA2611869A1 (fr) | 2006-12-21 |
| US20080194528A1 (en) | 2008-08-14 |
| FR2887150B1 (fr) | 2007-08-03 |
| CY1109507T1 (el) | 2014-08-13 |
| WO2006134272A1 (fr) | 2006-12-21 |
| DK1893237T3 (da) | 2009-11-09 |
| EP1893237A1 (fr) | 2008-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4442241A3 (en) | Retinol replacement in skin treatment | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
| PL371853A1 (pl) | Miejscowe kompozycje farmaceutyczne zawierające proantocyjanidyny do leczenia zapalenia skóry | |
| WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
| TW200744661A (en) | Topical cosmetic formulations for regulating and improving the moisture content of the skin | |
| CY1109507T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια | |
| MX2009005308A (es) | Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos. | |
| MX2010003258A (es) | Utilizacion de un nuevo agente natural en composiciones cosmeticas. | |
| CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
| TW200605870A (en) | Topical methadone compositions and methods for using the same | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| EP2144608A4 (en) | SUN PROTECTION COMPOSITIONS AND METHODS | |
| ES2267706T3 (es) | Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel. | |
| MX2007006539A (es) | Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel. | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| BRPI0512357A (pt) | composições compreendendo estrÈncio e vitamina d e usos destas | |
| TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
| MXPA05014184A (es) | Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral. | |
| ATE399558T1 (de) | Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln | |
| SE0203817D0 (sv) | New composition | |
| MX2007013449A (es) | Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo. | |
| DK1620116T3 (da) | Anvendelse af cinchona til fremstilling af et l gemiddel, som stimulerer angiogenese | |
| MX2009001631A (es) | Formulacion farmaceutica para el tratamiento de afecciones en la piel. | |
| MX2008006476A (es) | Composiciones de lipopeptidos. |